[go: up one dir, main page]

BR9813318A - Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient - Google Patents

Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient

Info

Publication number
BR9813318A
BR9813318A BR9813318-7A BR9813318A BR9813318A BR 9813318 A BR9813318 A BR 9813318A BR 9813318 A BR9813318 A BR 9813318A BR 9813318 A BR9813318 A BR 9813318A
Authority
BR
Brazil
Prior art keywords
human
macular degeneration
veterinary patient
treating tumors
pharmaceutical composition
Prior art date
Application number
BR9813318-7A
Other languages
Portuguese (pt)
Inventor
Yat Sun Or
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR9813318A publication Critical patent/BR9813318A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"PROCESSO DE TRATAMENTO DE TUMORES E DEGENERAçãO MACULAR EM PACIENTE HUMANO OU VETERINáRIO, COMPOSIçãO FARMACêUTICA PARA TRATAMENTO DE TUMORES E DEGENERAçãO MACULAR EM UM PACIENTE HUMANO OU VETERINáRIO". Um processo para o tratamento de tumores e degeneração macular em um paciente humano ou veterinário compreendendo a administração de um composto selecionado do grupo constituído de (I), (II), (III), (IV), (V), (VI), (VII), e uma composição farmacêutica compreendendo um veículo farmaceuticamente aceitável e um composto do grupo citado."TUMOR TREATMENT PROCESS AND MACULAR DEGENERATION IN HUMAN OR VETERINARY PATIENTS, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUMORS AND MACULAR DEGENERATION IN A HUMAN OR VETERINARY PATIENT". A process for the treatment of tumors and macular degeneration in a human or veterinary patient comprising administering a compound selected from the group consisting of (I), (II), (III), (IV), (V), (VI) , (VII), and a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the aforementioned group.

BR9813318-7A 1997-10-31 1998-10-30 Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient BR9813318A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31
PCT/US1998/023043 WO1999022722A2 (en) 1997-10-31 1998-10-30 Use of macrolides for the treatment of cancer and macular degeneration

Publications (1)

Publication Number Publication Date
BR9813318A true BR9813318A (en) 2000-08-22

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813318-7A BR9813318A (en) 1997-10-31 1998-10-30 Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient

Country Status (17)

Country Link
EP (1) EP1027060A2 (en)
JP (1) JP2001521891A (en)
KR (1) KR20010031577A (en)
CN (1) CN1278178A (en)
AR (1) AR043071A1 (en)
AU (1) AU1206799A (en)
BG (1) BG104436A (en)
BR (1) BR9813318A (en)
CA (1) CA2307850A1 (en)
HU (1) HUP0100012A3 (en)
IL (1) IL135518A0 (en)
NO (1) NO20002189L (en)
PL (1) PL340604A1 (en)
SK (1) SK6172000A3 (en)
TR (1) TR200001147T2 (en)
WO (1) WO1999022722A2 (en)
ZA (1) ZA989885B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140936D1 (en) 2000-04-13 2010-02-11 Biotica Tech Ltd GLYCOSYLATED HYBRID COMPOUNDS, THEIR PREPARATION AND USE
JP2006511475A (en) 2002-09-18 2006-04-06 トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア Method for suppressing choroidal neovascular disease
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
JP4928937B2 (en) * 2003-03-28 2012-05-09 スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ Migrastatin analogs and uses thereof
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
WO2005027906A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
CN1950388A (en) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 Macrocyclic compounds and methods of making and using the same
EP2716647A3 (en) * 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
WO2006001967A2 (en) 2004-05-25 2006-01-05 Sloan-Kettering Institute For Cancer Research Migrastatin analogs in the treatment of cancer
WO2006034478A2 (en) 2004-09-23 2006-03-30 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
KR20070104931A (en) 2005-02-09 2007-10-29 마커사이트, 인코포레이티드 Preparations for Eye Treatment
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
JP2009506063A (en) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ，インコーポレイテッド Triazole compounds and methods for making and using the same
EP3290427A1 (en) 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
KR20140093764A (en) 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 Stable formulations, and methods of their preparation and use
PL2001466T3 (en) 2006-03-23 2016-06-30 Santen Pharmaceutical Co Ltd Low-dose rapamycin for the treatment of vascular permeability-related diseases
CN106317146B (en) * 2015-06-18 2019-06-21 沈阳药科大学 Bicyclic clarithromycin derivatives and their use as tumor cell proliferation inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
SK6172000A3 (en) 2001-03-12
EP1027060A2 (en) 2000-08-16
WO1999022722A3 (en) 1999-08-05
WO1999022722A2 (en) 1999-05-14
PL340604A1 (en) 2001-02-12
JP2001521891A (en) 2001-11-13
CN1278178A (en) 2000-12-27
AU1206799A (en) 1999-05-24
TR200001147T2 (en) 2000-08-21
HUP0100012A2 (en) 2001-05-28
HUP0100012A3 (en) 2003-07-28
KR20010031577A (en) 2001-04-16
CA2307850A1 (en) 1999-05-14
NO20002189L (en) 2000-06-28
NO20002189D0 (en) 2000-04-27
BG104436A (en) 2000-12-29
ZA989885B (en) 1999-05-05
AR043071A1 (en) 2005-07-20
IL135518A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
BR9813318A (en) Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient
BR9813373A (en) Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and, processes for effecting immunosuppression and for treating or reducing the risk of reversibly obstructive airway disease in a patient
ATE307608T1 (en) COMBINATION OF DOCTAXEL AND RHUMAB HER2 FOR CANCER TREATMENT
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
BR0209658A (en) 4-Amino-5-phenyl-7-1-cyclobutyl-pyrrolo [2,3-d] pyrimidine derivatives
BR9715022A (en) Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations
DE69127175D1 (en) Antisense oligonucleotides for the treatment of cancer
DE69533112T2 (en) USE OF FLAVOLIGNANES FOR THE PRODUCTION OF MEDICINES WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, BREAST, EGGS
ATE319447T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING CLAVULANIC ACID OR DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
BG101118A (en) Therapeutical compounds
BR9500436A (en) Products use of a g-csf use of a tnf protein ligand process for the treatment and / or prevention of septic shock
BR9908510A (en) Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease
DE69200711D1 (en) Pharmaceutical compositions containing fluticasone propionate and oxikonazole or its salt for topical use.
BR9814419A (en) "combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases"
ATE334589T1 (en) ANTI-ARRHYTHMIC COMPOSITIONS AND TREATMENT METHODS
DE69916488D1 (en) SUBSTITUTED CAPROLACTAM DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT OF TUMORS
DE69924483D1 (en) COMBINATION THERAPY FOR THE TREATMENT OF TUMORS
MXPA00010254A (en) The treatment of sexual dysfunction in certain patient groups.
DE69733169D1 (en) Use of alpha 1 adrenoceptor antagonists for the manufacture of a medicament for the prevention and treatment of cancer
GR3032224T3 (en) Therapeutic agent for threatened abortion.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE69314586D1 (en) Medicament composition containing TCF-II
BR0014751A (en) Compound, stereoisomer or mixture of stereoisomers, pharmaceutical composition, method of treating a patient in need of antimicrobial treatment, and use of a compound
KR900017599A (en) Pharmaceutical composition for tumor treatment
BR9810930A (en) Pharmaceutical compositions of arglabine and arglabine derivatives

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.